{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:23725625",
      "entity_text" : "olaparib",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:10077147",
      "entity_text" : "BX795",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Both BX795 and anti-IFNAR1antibody attenuated the antitumor activity of olaparib on PBM tumors, indicating that activation of the STING pathway and type I IFN responses are important for the antitumor activity of olaparib in Brca deficient tumors.",
  "reading_complete" : "2020-08-08T07:39:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T07:37:30Z",
  "trigger" : "attenuated",
  "evidence" : [ "BX795 and anti-IFNAR1antibody attenuated the antitumor activity of olaparib on PBM tumors                                   , indicating that activation of the STING pathway and type I IFN responses are important for the antitumor activity of olaparib" ],
  "pmc_id" : "6366450",
  "score" : 0
}